BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3140572)

  • 21. Bromocriptine and premenstrual tension: a clinical and hormonal study.
    Andersch B; Hahn L
    Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.
    Freeman E; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone and the premenstrual syndrome: a double blind crossover trial.
    Dennerstein L; Spencer-Gardner C; Gotts G; Brown JB; Smith MA; Burrows GD
    Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1617-21. PubMed ID: 3924191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
    Schmidt PJ; Grover GN; Rubinow DR
    Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo.
    Sampson GA
    Br J Psychiatry; 1979 Sep; 135():209-15. PubMed ID: 385093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
    Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
    Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of premenstrual symptoms with mefenamic acid.
    Wood C; Jakubowicz D
    Br J Obstet Gynaecol; 1980 Jul; 87(7):627-30. PubMed ID: 7000168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome.
    Emperaire JC; Ruffie A
    Hum Reprod; 1991 Apr; 6(4):506-10. PubMed ID: 1918298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
    Wang M; Hammarbäck S; Lindhe BA; Bäckström T
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome.
    Hahn PM; Van Vugt DA; Reid RL
    Psychoneuroendocrinology; 1995; 20(2):193-209. PubMed ID: 7899538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No effect of vitamin B-6 against premenstrual tension. A controlled clinical study.
    Hagen I; Nesheim BI; Tuntland T
    Acta Obstet Gynecol Scand; 1985; 64(8):667-70. PubMed ID: 3914180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes.
    Halbreich U; Rojansky N; Palter S
    Fertil Steril; 1991 Dec; 56(6):1066-9. PubMed ID: 1743323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LHRH analogue treatment for the prevention of premenstrual attacks of acute porphyria.
    Herrick AL; McColl KE; Wallace AM; Moore MR; Goldberg A
    Q J Med; 1990 Apr; 75(276):355-63. PubMed ID: 2117297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premenstrual syndrome in Cape Town. Part II. A double-blind placebo-controlled study of the efficacy of mefenamic acid.
    Gunston KD
    S Afr Med J; 1986 Aug; 70(3):159-60. PubMed ID: 3526590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome.
    Smith RN; Studd JW; Zamblera D; Holland EF
    Br J Obstet Gynaecol; 1995 Jun; 102(6):475-84. PubMed ID: 7632640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome.
    Franks S; Sagle M; Mason HD; Kiddy D
    Horm Res; 1987; 28(2-4):164-8. PubMed ID: 3136067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine treatment of the premenstrual syndrome.
    Kullander S; Svanberg L
    Acta Obstet Gynecol Scand; 1979; 58(4):375-8. PubMed ID: 393053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of premenstrual syndrome. A double-blind trial of dydrogesterone.
    Dennerstein L; Morse C; Gotts G; Brown J; Smith M; Oats J; Burrows G
    J Affect Disord; 1986; 11(3):199-205. PubMed ID: 2951407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.